Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 59
Filter
1.
J Viral Hepat ; 10(4): 324-30, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12823601

ABSTRACT

We aimed to assess the clinical performance of a newly developed chemiluminescence enzyme immunoassay (CLEIA) for the detection of hepatitis B virus (HBV) core-related antigen (HBcrAg) in patients with chronic HBV infection. A total of 82 patients with chronic HBV infection and 167 HBV-negative controls were studied. HBcrAg was measured by CLEIA with monoclonal antibodies to hepatitis B e antigen (HBeAg) and hepatitis B core antigen (HBcAg), and HBV DNA was measured by transcription-mediated amplification assay (TMA) and in-house real-time detection polymerase chain reaction (RTD-PCR). The HBcrAg assay detected viremia in 189 of 216 samples (88%) collected from 72 patients whilst the TMA assay detected viremia in 178 of the 216 samples (82%) (P = 0.019). The HBcrAg concentration correlated linearly with the HBV DNA concentration (P < 0.001) over a range which varied 100 000-fold. The accuracy in the measurement of the patients' HBV load obtained using the HBcrAg assay was not affected by the absence of hepatitis B e antigen from the serum or the presence of precore mutations in the HBV genome. In patients without anti-viral drugs, changes in their serum HBcrAg concentration over time corresponded to their HBV DNA concentration. In six additional patients who were later treated with lamivudine, HBV DNA concentration declined more rapidly than their HBcrAg concentration. Three months after treatment commenced, the ratio of HBcrAg: HBV DNA had increased in all six patients (P = 0.031). The HBcrAg assay is a sensitive and useful test for the assessment of a patient's HBV load. When monitoring the anti-viral effect of lamivudine, HBcrAg provides a viral marker which is independent of HBV DNA.


Subject(s)
Hepatitis B Core Antigens/analysis , Hepatitis B virus/drug effects , Hepatitis B/drug therapy , Immunoenzyme Techniques/methods , Lamivudine/therapeutic use , Biomarkers/analysis , Case-Control Studies , Cohort Studies , DNA, Viral/analysis , Female , Follow-Up Studies , Hepatitis B/diagnosis , Hepatitis B/immunology , Hepatitis B Core Antigens/drug effects , Hepatitis B virus/immunology , Humans , Male , Monitoring, Physiologic/methods , Probability , Reference Values , Treatment Outcome
2.
Tissue Antigens ; 61(2): 159-65, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12694584

ABSTRACT

Hepatitis C virus (HCV) causes various grades of chronic liver disease, ranging from an asymptomatic state to cirrhosis. To assess genetic factors of disease severity, we selected two HCV patient groups according to the following stringent criteria: (i) asymptomatic carrier state (ASC) defined by HCV infection for more than 20 years, normal alanine aminotransferase levels for the past 5 years as well as normal liver histology and/or shape and (ii) liver cirrhosis (LC) as diagnosed by clinical symptoms, liver biopsy and/or ultrasonography. A total of 103 chronically infected Japanese HCV patients (43 ASC and 60 LC) were analyzed. HLA class I and II alleles were established using low resolution DNA typing. HLA-DRB1 and DQB1 genotypes were inferred upon polymerase chain reaction-restriction fragment length polymorphism analysis. Two hundred and one anti-HCV-negative ethnically matched controls were included. The frequencies of DRB1*12 (*1201 and *1202), DQB1*0301 and DRB3*03 alleles were higher in patients with ASC than in those with LC (odds ratio (OR) 11.23, OR 4.25, and OR 3.22, respectively). The frequency of DQB1*0503 were lower in ASC patients compared to LC patients (OR 0.05). No significant differences between groups were observed for age, sex, source of infection, HCV genotype or viral loads. Our findings establish that certain HLA class II alleles strongly influence disease progression following HCV infection.


Subject(s)
Genes, MHC Class II , HLA Antigens/genetics , Hepatitis C, Chronic/genetics , Hepatitis C, Chronic/immunology , Aged , Alleles , Carrier State/immunology , Case-Control Studies , Female , Follow-Up Studies , Gene Frequency , Genes, MHC Class I , Genotype , Hepatitis C, Chronic/complications , Humans , Japan , Liver Cirrhosis/etiology , Liver Cirrhosis/genetics , Liver Cirrhosis/immunology , Male , Middle Aged
3.
Biol Pharm Bull ; 24(7): 772-6, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11456116

ABSTRACT

Our previous study has demonstrated that the exposure of male BALB/c mice to social isolation stress caused a suppressed immune response and enhanced liver metastasis of colon 26-L5 carcinoma cells. To more precisely understand the influence of psychosocial factors on the metastatic process, here we have investigated the effect of social isolation stress on the vulnerability of the host to develop liver metastasis of colon 26-L5 cells, including the time span and incidence of metastatic formation, survival time and chemotherapy response. Isolation stress decreased the time period required for the metastasis formation relative to that in controls. On day 7 after the tumor injection, the 75% incidence of tumor metastasis in the stressed mice was 5 times the 15% incidence in the unstressed mice. When exposed to the challenge of lower cell numbers (0.025, 0.05, 0.1 x 10(4)/mouse) of colon 26-L5 cells, mice subjected to isolation stress developed an elevated incidence of metastasis (33.3, 66.6, and 100%, respectively) as compared with the controls (0, 33.3 and 50%, respectively). The survival time following the tumor inoculation was also shorter in the stressed mice (21.83 +/- 1.59d) than in the control mice (24.08 +/- 1.68 d). Furthermore, the response of liver metastasis to chemotherapy consisting of 2 mg/kg cisplatin (CDDP) was worse in the stressed mice than that in unstressed mice. These findings suggested that social isolation stress could significantly impair the resistance of mice to the development of metastasis.


Subject(s)
Colonic Neoplasms/pathology , Liver Neoplasms/pathology , Liver Neoplasms/secondary , Social Isolation , Stress, Psychological/pathology , Animals , Antineoplastic Agents/therapeutic use , Cisplatin/therapeutic use , Colonic Neoplasms/drug therapy , Immunity, Innate/physiology , Liver Neoplasms/drug therapy , Male , Mice , Mice, Inbred BALB C , Neoplasm Transplantation , Survival Analysis , Tumor Cells, Cultured
5.
Cancer Lett ; 165(1): 35-42, 2001 Apr 10.
Article in English | MEDLINE | ID: mdl-11248416

ABSTRACT

We examined the effect of berberine, a major component with anti-fungal properties contained in Coptidis Rhizoma and Phellodendri Cortex, on the lymph node metastasis of murine lung cancer. Oral administration of berberine for 14 days significantly inhibited the spontaneous mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma (LLC) into the lung parenchyma in a dose-dependent manner, but did not affect the tumor growth at the implantation site of the lung. Combined treatment with berberine and an anti-cancer drug, CPT-11, resulted in a marked inhibition of tumor growth at the implantation site and of lymphatic metastasis, as compared with either treatment alone. Anti-activator protein-1 (anti-AP-1) transcriptional activity of non-cytotoxic concentrations of berberine caused the inhibition of the invasiveness of LLC cells through the repression of expression of urokinase-type plasminogen activator (u-PA).


Subject(s)
Berberine/therapeutic use , Camptothecin/analogs & derivatives , Carcinoma, Lewis Lung/secondary , Lung Neoplasms/pathology , Mediastinal Neoplasms/prevention & control , Animals , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Camptothecin/therapeutic use , Carcinoma, Lewis Lung/prevention & control , Disease Models, Animal , Female , Irinotecan , Lung Neoplasms/prevention & control , Lymphatic Metastasis , Mice , Mice, Inbred C57BL , Neoplasm Invasiveness/prevention & control , Neoplasm Transplantation , Transcription Factor AP-1/antagonists & inhibitors
6.
Tumour Biol ; 22(3): 154-61, 2001.
Article in English | MEDLINE | ID: mdl-11275793

ABSTRACT

Intrahepatic metastasis is a major modality in the recurrence of hepatoma. Establishment of the intrahepatic metastasis model would be useful for evaluating new anticancer therapies and analyzing the molecular mechanisms of tumor metastasis. Orthotopic implantation of a fragment of CBO140C12 hepatoma into the liver resulted in the formation of a solitary tumor nodule and its intrahepatic metastasis. In contrast, implantation of ADras3 cancer cells did not show any metastasis on day 21. CBO140C12 cells showed enhancement of the invasive, adhesive and migratory capabilities, as compared with ADras3 cells. Furthermore, mRNA expression and gelatinolytic activity of MMP-9 were detected in CBO140C12 cells, and the expression of mRNA for MT1-MMP in CBO140C12 cells was greater than that in ADras3 cells. Thus, intrahepatic metastasis of CBO140C12 tumor might be involved in the enhancement of the invasiveness of tumor cells via marked expression of MMP-9 and MT1-MMP.


Subject(s)
Liver Neoplasms, Experimental/pathology , Neoplasm Invasiveness , Animals , Disease Models, Animal , Female , Gelatinases/metabolism , Liver Neoplasms, Experimental/secondary , Matrix Metalloproteinase 14 , Matrix Metalloproteinase 9/metabolism , Matrix Metalloproteinases, Membrane-Associated , Metalloendopeptidases/metabolism , Mice , Mice, Inbred C3H , Neoplasm Transplantation , RNA, Messenger/metabolism , Tumor Cells, Cultured
7.
Anticancer Res ; 20(5A): 2931-7, 2000.
Article in English | MEDLINE | ID: mdl-11062703

ABSTRACT

Several studies have shown that the Kampo medicine Juzen-taiho-to (Si-Quan-Da-Bu-Tang in Chinese) has various biological activities, including anti-tumor effects when combined with surgical excision or with chemotherapeutic drugs. Here we investigated the effect of combined therapy with interferon (IFN)-alpha A/D and Juzen-taiho-to on experimental lung metastasis of murine renal cell carcinoma (Renca) cells. Five consecutive administrations of IFN-alpha A/D to Renca-bearing mice resulted in dose-dependent inhibition of lung metastasis. IFN-alpha A/D at the dose of 100,000 IU/mouse significantly inhibited the metastasis, but a marked loss of body weight was observed during and after the administration. In contrast, oral administration of Juzen-taiho-to (50 mg/mouse) alone tended to inhibit the metastasis, but the effect was not statistically significant. The combination treatment of suboptimal doses of IFN-alpha A/D and Juzen-taiho-to markedly augmented the antimetastatic effect without causing any loss of body weight, as compared with either treatment alone. Similar results were also obtained by treatment with IFN-gamma in combination with Juzen-taiho-to. Clinically, immunotherapy with IFNs has been primarily approved for the treatment of patients with metastatic renal cell carcinoma, but sufficient efficacy has not yet been obtained. Therefore, the combination of IFNs with Juzen-taiho-to may provide a means to increase the therapeutic potential of IFNs and to decrease their toxicity for the treatment of metastatic renal cell carcinoma.


Subject(s)
Adjuvants, Immunologic/therapeutic use , Antineoplastic Agents/therapeutic use , Carcinoma, Renal Cell/drug therapy , Drugs, Chinese Herbal/therapeutic use , Interferon Type I/therapeutic use , Kidney Neoplasms/drug therapy , Lung Neoplasms/secondary , Animals , Carcinoma, Renal Cell/physiopathology , Disease Models, Animal , Drug Therapy, Combination , Female , Injections, Intravenous , Interferon-alpha , Kidney Neoplasms/physiopathology , Lung , Lung Neoplasms/prevention & control , Medicine, Kampo , Mice , Mice, Inbred BALB C , Neoplasm Metastasis , Recombinant Fusion Proteins/therapeutic use , Recombinant Proteins
8.
Neoplasia ; 2(4): 315-24, 2000.
Article in English | MEDLINE | ID: mdl-11005566

ABSTRACT

We examined the tumorigenic and metastatic potentials of three human non-small cell lung cancer (NSCLC) cell lines, PC-14, A549 or Lu-99 cell lines suspended in Matrigel-containing phosphate-buffered saline were orthotopically implanted into the lungs of nude mice. The formation of a solitary tumor nodule in the lung was observed after the implantation of all cell lines. Intrapulmonary implantation of PC-14 or Lu-99 cells resulted in spontaneous distant metastases. In contrast, A549 cells caused multiple intrapulmonary metastases to the right and left lobes of the lung without producing visible lymphatic metastasis. We also investigated the expression of matrix metalloproteinases (MMPs), urokinase-type plasminogen activator (u-PA), u-PA receptor (u-PAR) and c-MET in these cell lines in vitro and in vivo. Reverse transcription polymerase chain reaction (RT-PCR) analysis showed that the expression of MMP-2 and membrane-type 1 MMP (MT1-MMP) was elevated in PC-14 as compared with the other two cell lines. In contrast, stronger expression of c-MET was observed in A549 than in PC-14 or Lu-99. These results indicate that differential patterns of metastasis of lung cancer might be associated with differential expression of metastasis-associated molecules. Our orthotopic implantation models display clinical features resembling those of NSCLC, and may provide a useful basis for lung cancer research.


Subject(s)
Carcinoma, Non-Small-Cell Lung/pathology , Lung Neoplasms/pathology , Lymphatic Metastasis , Adenocarcinoma/genetics , Adenocarcinoma/pathology , Animals , Carcinoma, Large Cell/genetics , Carcinoma, Large Cell/pathology , Carcinoma, Non-Small-Cell Lung/genetics , Humans , Lung Neoplasms/genetics , Male , Matrix Metalloproteinase 1/analysis , Matrix Metalloproteinase 1/genetics , Matrix Metalloproteinase 2/analysis , Matrix Metalloproteinase 2/genetics , Mice , Mice, Nude , Receptors, Cell Surface/analysis , Receptors, Cell Surface/genetics , Receptors, Urokinase Plasminogen Activator , Reverse Transcriptase Polymerase Chain Reaction , Transplantation, Heterologous , Tumor Cells, Cultured , Urokinase-Type Plasminogen Activator/analysis , Urokinase-Type Plasminogen Activator/genetics
9.
Life Sci ; 66(19): 1827-38, 2000 Mar 31.
Article in English | MEDLINE | ID: mdl-10809180

ABSTRACT

We investigated the effect of social isolation stress on the formation of experimental liver metastasis resulted from intraportal vein (i.p.v.) injection of colon 26-L5 carcinoma cells in male Balb/c mice, and elucidated some of the underlying mechanism involving the effects of this stress on cellular immunity. Increases in the colony number and tumor burden were observed in the mice socially isolated before and/or after tumor cell challenge, as compared with the group-housed mice. In addition, exposure of mice to 2 weeks of preisolation resulted in decreases in the thymus weight and number of thymocytes by 35.8% and 40.2%, respectively, in comparison with the controls. Reduced proliferative response of splenocytes to various stimuli and suppressed splenic NK activity, as well as decreased macrophage-mediated cytotoxicity, were also found in the mice exposed to social isolation. Thus, these results suggest that social isolation stress enhances tumor metastasis in part via its suppressive effect on the immune system of the host.


Subject(s)
Carcinoma/pathology , Colonic Neoplasms/pathology , Immunity, Cellular/physiology , Liver Neoplasms, Experimental/secondary , Social Isolation/psychology , Stress, Psychological/pathology , Animals , Carcinoma/immunology , Cell Count , Cell Line , Cell Survival/drug effects , Cell Transplantation , Colonic Neoplasms/immunology , Killer Cells, Natural/immunology , Killer Cells, Natural/physiology , Liver Neoplasms, Experimental/immunology , Liver Neoplasms, Experimental/pathology , Macrophages/drug effects , Macrophages/immunology , Male , Mice , Mice, Inbred BALB C , Neoplasm Transplantation , Organ Size/physiology , Spleen/cytology , Spleen/drug effects , Stress, Psychological/immunology
10.
Cancer Lett ; 155(2): 173-9, 2000 Jul 31.
Article in English | MEDLINE | ID: mdl-10822133

ABSTRACT

Membrane-type metalloproteinase-1 (MT1-MMP) is a transmembrane metalloproteinase, which activates proMMP-2 and expressed on the cell surface in many invasive cancer cells. We investigated the expression of MT1-MMP in prostate cancer cell lines. MT1-MMP protein and mRNA were expressed in PC-3, DU-145 and TSU-pr1 cells (androgen-independent prostate cancer cell lines), but in LNCaP cells (androgen-dependent prostate cancer cell line). MT1-MMP protein was negative and mRNA was low to detect by RT-PCR. Cell lysate of PC-3 cleaved proMMP-2 to the active form. In addition, both hepatocyte growth factor (HGF) and gastrin-releasing peptide (GRP) increased Matrigel invasion and induced the expression of MT1-MMP protein in DU-145 prostate cancer cells. These results suggest that MT1-MMP is indeed the tumor-specific activator of proMMP-2 in androgen-independent prostate cancer cells and plays an important role in the invasive properties of prostate cancer cells.


Subject(s)
Metalloendopeptidases/metabolism , Prostatic Neoplasms/metabolism , Catalysis , Collagen/metabolism , Dose-Response Relationship, Drug , Drug Combinations , Enzyme Activation , Flow Cytometry , Gastrin-Releasing Peptide/metabolism , Hepatocyte Growth Factor/metabolism , Humans , Laminin/metabolism , Male , Matrix Metalloproteinase 2/biosynthesis , Matrix Metalloproteinases, Membrane-Associated , Neoplasm Invasiveness , Protein Precursors/biosynthesis , Proteoglycans/metabolism , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Tumor Cells, Cultured
11.
Jpn Circ J ; 64(2): 135-8, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10716528

ABSTRACT

We experienced a long-term survival case of primary cardiac lymphoma (PCL) demonstrating ventricular tachycardia (VT) as an initial sign, which was related to localized myocardial damage by lymphoma cells. A 70-year-old woman with sustained VT was admitted to the Kofu Municipal Hospital. VT ceased with the administration of disopyramide intravenously. The origin of the VT was the free wall of the right ventricular outflow tract (RVOT) as observed by electrocardiography on admission. A solitary mass in the free wall of the RVOT was found by echocardiography, chest computed tomographic scanning and magnetic resonance imaging. There was no evidence of extracardiac involvement. The patient was histologically diagnosed as PCL by endomyocardial biopsy. Chemotherapy started immediately after the diagnosis and the mass showed a marked reduction in size. After 8 cycles of chemotherapy, radiotherapy was performed. Pericardial thickness in the free wall of the RVOT developed without severe side effects. Complete remission has been maintained for 30 months after the initial diagnosis, and no recurrence and arrhythmias have been detected during the follow-up period. It was demonstrated that rapid diagnosis and chemotherapy followed by radiotherapy for PCL achieved better survival.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Heart Neoplasms , Lymphoma, B-Cell , Tachycardia, Ventricular , Aged , Female , Heart Neoplasms/complications , Heart Neoplasms/drug therapy , Heart Neoplasms/physiopathology , Heart Neoplasms/radiotherapy , Humans , Lymphoma, B-Cell/complications , Lymphoma, B-Cell/drug therapy , Lymphoma, B-Cell/physiopathology , Lymphoma, B-Cell/radiotherapy , Remission Induction , Tachycardia, Ventricular/etiology , Tachycardia, Ventricular/physiopathology
12.
Clin Exp Metastasis ; 18(1): 1-10, 2000.
Article in English | MEDLINE | ID: mdl-11206831

ABSTRACT

We have previously shown that tumor necrosis factor-alpha (TNF-alpha), which is an important angiogenesis-related factor, was over-secreted in male BALB/c mice under social isolation stress as compared with the control, and closely associated with a remarkable elevation of tumor invasion and metastasis of colon 26-L5 carcinoma cells. In the present study, we explored the effect of isolation stress on the angiogenesis caused by colon 26-L5 carcinoma cells in vivo and in vitro. Social isolation lead to the enhancement of tumor growth after intrahepatic implantation with a fragment of colon 26-L5 tumor. Angiogenic response (number of vessels oriented towards tumor mass) and tumor growth (size) were significantly increased in the socially isolated mouse relative to that in the group-housed mice. Furthermore, higher protein level of hepatic TNF-alpha was found in the stressed mice than that in the control. Expression of mRNA for vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) were also elevated in the tumor regions and liver tissues of the stressed mice in comparison with that in group-housed mice. On the other hand, hepatic sinusoidal endothelial (HSE) cells treated with TNF-alpha exhibited a marked promotion of the migration, invasion, expression of mRNA for matrix metalloproteinase (MMP)-9, and tube-like formation, but no cytotoxicity against the cells in vitro. The above data suggest that the social isolation stress augmented the tumor-induced angiogenesis probably by up-regulating the angiogenesis-related factors, including TNF-alpha, VEGF and HGF, and consequently mediating the functions of endothelial cells such as migration, invasion, and tube-like formation.


Subject(s)
Colonic Neoplasms/blood supply , Neovascularization, Pathologic , Social Isolation , Stress, Physiological/pathology , Animals , Base Sequence , Colonic Neoplasms/pathology , DNA Primers , Liver Neoplasms, Experimental/pathology , Liver Neoplasms, Experimental/secondary , Male , Mice , Mice, Inbred BALB C , Neoplasm Transplantation , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction , Stress, Physiological/metabolism , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism , Tumor Necrosis Factor-alpha/physiology
13.
Chem Pharm Bull (Tokyo) ; 47(8): 1170-4, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10478473

ABSTRACT

Our previous study demonstrated that the oral administration of Juzen-taiho-to resulted in a significant inhibition of the liver metastasis of colon 26-L5 cells as compared with the untreated control, without side effects. We attempted to investigate the relationship between the HPLC pattern (referred to as the fingerprint) of the formulation and its component crude drugs and the inhibition of tumor metastasis in order to obtain the optimal efficacy and constant quality of the formulation. Two Juzen-taiho-to formulations (batches #1 and #2), which were individually prepared using the same 10 crude drugs and the same preparation procedure, showed similar anti-metastatic effects and absorbance patterns by HPLC analysis. Some variant formulations of Juzen-taiho-to, in which one crude drug was substituted with other crude drugs from different sources or places of origin, exhibited reduced efficacy as compared with the original formulation, as well as differences in the fingerprint pattern compared with the original formulation. Juzen (Naimo-Ogi-->Kibana-Ogi), a variant formulation with the substitution of Astragali radix of a different origin and place of harvest, showed significant inhibition of the liver metastasis of tumor cells and a HPLC fingerprint pattern similar to that of the original formulation. Thus, HPLC fingerprint analysis of Kampo medicines may provide a useful basis for obtaining their optimal efficacy as well as constant quality of the formulation, although it has some problems and limitations, such as detectability by and sensitivity to UV absorbance.


Subject(s)
Antineoplastic Agents, Phytogenic/analysis , Antineoplastic Agents, Phytogenic/pharmacology , Drugs, Chinese Herbal/analysis , Drugs, Chinese Herbal/pharmacology , Neoplasm Metastasis/prevention & control , Animals , Chromatography, High Pressure Liquid , Colonic Neoplasms/drug therapy , Colonic Neoplasms/pathology , Female , Liver Neoplasms/pathology , Liver Neoplasms/prevention & control , Liver Neoplasms/secondary , Mice , Mice, Inbred BALB C , Neoplasm Metastasis/pathology , Neoplasm Transplantation , Spectrophotometry, Ultraviolet
14.
Arzneimittelforschung ; 49(6): 519-26, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10417869

ABSTRACT

Lafutidine (CAS 118288-08-7, FRG-8813) is a novel histamine H2-receptor antagonist with gastroprotective activity. The aim of this study was to investigate the property of the gastro-protective activity of lafutidine by examining the effect on ammonia-induced change in transmucosal potential difference (PD), basal gastric mucosal blood flow (GMBF) and noxious agent-induced cell damage. Intragastrical application of lafutidine accelerated the recovery of the PD reduction after exposure of the mucosa to 0.25% ammonia solution and the accelerating effect was abolished by chemical deafferentation, but not with indometacin, a cyclooxygenase inhibitor. The application of capsaicin, as a reference compound, significantly promoted the recovery of the ammonia-induced PD reduction and this effect was not altered with indometacin. Lafutidine given intragastrically caused a sustained increase in GMBF in a dose-dependent fashion, which was also completely inhibited in the deafferentated rats. In vitro studies revealed that, in contrast to 16,16-dimethyl prostaglandin E2, lafutidine did not protect isolated gastric superficial epithelial cells from ethanol- or ammonia-induced damage. In conclusion, the gastroprotection of lafutidine is induced by promoting the restitution of the damaged mucosa after a noxious agent, not by directly protecting the epithelial cells and this effect may be caused through the mechanism of capsaicin-sensitive afferent nerves.


Subject(s)
Acetamides/therapeutic use , Anti-Ulcer Agents/therapeutic use , Histamine H2 Antagonists/therapeutic use , Piperidines/therapeutic use , Pyridines/therapeutic use , Stomach Ulcer/prevention & control , 16,16-Dimethylprostaglandin E2/pharmacology , Ammonia , Animals , Anti-Inflammatory Agents, Non-Steroidal , Capsaicin/pharmacology , Central Nervous System Depressants , Ethanol , Gastric Mucosa/pathology , Indomethacin , Male , Membrane Potentials/drug effects , Rats , Rats, Sprague-Dawley , Stomach Ulcer/chemically induced , Stomach Ulcer/pathology
15.
Digestion ; 60(4): 338-43, 1999.
Article in English | MEDLINE | ID: mdl-10394028

ABSTRACT

BACKGROUND/AIM: There have been only a few studies on the distribution of calcitonin gene-related peptide (CGRP) in the human stomach, in which it was stated that CGRP fibers are rare in that organ. The aim of the present study was to investigate the immunohistochemical localization of CGRP in the human gastric mucosa obtained by endoscopic biopsy from patients with gastric ulcers. METHODS: Immunohistochemistry was carried out according to the indirect immunoperoxidase method using an anti-human CGRP antibody. Biopsies were taken from the ulcer margin in 18 patients (age 37-78, average 57.4 years) and from two endoscopically normal portions (antrum and body) in 7 other patients (age 36-65, average 51.0 years). One biopsy specimen was obtained from each portion. RESULTS: Twelve of the eighteen biopsy specimens from the ulcer margin, 6 of the 7 biopsy specimens from normal portions of the antrum and 3 of the 7 biopsy specimens from normal portions of the body showed CGRP-immunoreactive staining. Intense staining was more marked in the specimens from the ulcer margin compared to those of the normal portions. CONCLUSIONS: CGRP immunoreactivity was observed in the human gastric mucosa in considerable abundance, and it is presumed that CGRP might participate in a restoration mechanism of the ulcer.


Subject(s)
Calcitonin Gene-Related Peptide/analysis , Gastric Mucosa/chemistry , Stomach Ulcer/metabolism , Adult , Aged , Biopsy , Female , Gastric Mucosa/pathology , Humans , Immunohistochemistry , Male , Middle Aged , Stomach Ulcer/pathology
16.
Br J Cancer ; 79(7-8): 1121-6, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10098745

ABSTRACT

This study is designed to establish a pulmonary tumour model to investigate the biology and therapy of lung cancer in mice. Current methods for forming a solitary intrapulmonary nodule and subsequent metastasis to mediastinal lymph nodes are not well defined. Lewis lung carcinoma (LLC) cell suspensions were orthotopically introduced into the lung parenchyma of C57/BL6 mice via a limited skin incision without thoracotomy followed by direct puncture through the intercostal space. The implantation process was performed within approximately 50 s per mouse, and the operative mortality was less than 5%. Single pulmonary nodules developed at the implanted site in 93% of animals and subsequent mediastinal lymph node metastasis was observed in all mice that formed a lung nodule after intrapulmonary implantation. The size of tumour nodule and the weight of mediastinal lymph node increased in a time-dependent manner. The mean survival time of mice implanted successfully with LLC cells was 21+/-2 days (range 19-24 days). Histopathological analysis revealed that no metastatic tumour was detectable in the mediastinal lymph nodes on day 11, but metastatic foci at mediastinal lymph nodes were clearly observed on days 17 and 21 after implantation. Other metastases in distant organs or lymph nodes were not observed at 21 days after the implantation. Comparative studies with intrapleural and intravenous injections of LLC cells suggest that the mediastinal lymph node metastasis by intrapulmonary implantation is due to the release of tumour cells from the primary nodule, and not due to extrapulmonary leakage of cells. An intravenous administration of cis-diamine dichloro platinum on day 1 after tumour implantation tended to suppress the primary tumour nodule and significantly inhibited lymph node metastasis. Thus, a solitary pulmonary tumour nodule model with lymph node metastasis approximates clinical lung cancer and may provide a useful basis for lung cancer research.


Subject(s)
Carcinoma, Lewis Lung/secondary , Animals , Antineoplastic Agents/therapeutic use , Carcinoma, Lewis Lung/drug therapy , Cisplatin/therapeutic use , Disease Models, Animal , Female , Lymphatic Metastasis , Mediastinum , Mice , Mice, Inbred C57BL , Neoplasm Transplantation/methods , Specific Pathogen-Free Organisms
17.
Hum Cell ; 12(4): 197-204, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10834106

ABSTRACT

This study is designed to establish a pulmonary tumor model to investigate the biology and therapy of lung cancer in mice. Current methods for forming a solitary intrapulmonary nodule and subsequent metastasis to mediastinal lymph nodes are not well defined. Lewis lung carcinoma cell (LLC) suspensions were orthotopically introduced into the lung parenchyma of C57/BL6 mice via a limited skin incision without thoracotomy followed by direct puncture through the intercostal space. The implantation process was performed within approximately 50 sec per mouse, and the operative mortality was less than 5%. Single pulmonary nodules developed at the implanted site in 93% of animals and subsequent mediastinal lymph nodes metastasis were observed in all mice that were succeeded to form a lung nodule after intrapulmonary implantation. The size of tumor nodule and the weight of mediastinal lymph node increased in a time-dependent manner. The mean survival time of mice implanted successfully with LLC cells was 21 +/- 2 days (range; 19-24 days). Histopathological analysis revealed that no metastatic tumor was detectable in the mediastinal lymph nodes on day 11, but metastatic foci at mediastinal lymph nodes were clearly observed on days 17 and 21 after implantation. Other metastases in distant organs or lymph nodes were not observed at 21 days after the implantation. Comparative studies with intrapleural and intravenous injections of LLC cells suggest that the mediastinal lymph node metastasis by intrapulmonary implantation is due to the release of tumor cells from the primary nodule, and not due to extrapulmonary leakage of cells. An intravenous administration of CDDP on day 1 after tumor implantation tended to suppress the primary tumor nodule and significantly inhibited the lymph node metastasis. Thus, a solitary pulmonary tumor nodule model with lymph node metastasis approximates clinical lung cancer, and may provide a useful basis for lung cancer research.


Subject(s)
Carcinoma, Lewis Lung/pathology , Lung Neoplasms/pathology , Lymph Nodes/pathology , Animals , Antineoplastic Agents/therapeutic use , Carcinoma, Lewis Lung/drug therapy , Cisplatin/therapeutic use , Disease Models, Animal , Female , Lung Neoplasms/drug therapy , Lymphatic Metastasis , Mediastinum , Mice , Mice, Inbred C57BL , Neoplasm Transplantation
18.
Oncol Res ; 11(10): 461-9, 1999.
Article in English | MEDLINE | ID: mdl-10850887

ABSTRACT

Psychosocial stress has been implicated in tumor metastasis. We have previously reported that social isolation stress exacerbated liver metastasis of colon 26-L5 by partially suppressing the cellular immunity in male Balb/c mice. To further understand the mechanism underlying the influence of isolation stress on liver metastasis, we investigated the effect of social isolation stress on tumor invasion, which is considered to be a pivotal step of tumor metastasis. The invasion and migration of tumor cells obtained from tumor nodules in the isolated mice were more markedly enhanced than that in the group-housed mice. The mRNA expression of proteolytic proteases, including matrix metalloproteinase (MMP)-2, MMP-9, membrane type 1 (MTI)-MMP, and urokinase-type plasminogen activator (u-PA), were increased in the tumor and liver tissues of the isolated mice compared with the control mice. On the other hand, production of plasma TNF-alpha and expression of hepatic TNF-alpha mRNA were elevated in the isolated mice with or without tumor burden. Increased TNF-alpha level was particularly discernible in the liver of tumor-bearing mice. Elevated positive staining for TNF-alpha was immunohistochemically observed within and around tumor mass in the liver from isolated tumor-bearing mice, compared with group-housed mice. In addition, the invasiveness of tumor cells and the expression of proteolytic enzymes, including MMP-9 and u-PA in tumor cells, were enhanced by the treatment of TNF-alpha in vitro. Thus, the data suggested that isolation stress-augmented TNF-alpha may be involved in the enhancement of tumor invasion and metastasis in part by upregulating the proteolytic enzymes such as MMPs and u-PA in tumor and liver tissues.


Subject(s)
Colonic Neoplasms/pathology , Liver Neoplasms/metabolism , Social Isolation , Stress, Psychological , Tumor Necrosis Factor-alpha/metabolism , Animals , Colonic Neoplasms/metabolism , Immunohistochemistry , Liver/metabolism , Male , Matrix Metalloproteinases/metabolism , Mice , Mice, Inbred BALB C , Neoplasm Invasiveness , Neoplasm Metastasis , Neoplasm Transplantation , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Tumor Cells, Cultured , Urokinase-Type Plasminogen Activator/metabolism
19.
Jpn J Cancer Res ; 90(11): 1254-61, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10622538

ABSTRACT

The anti-tumor and anti-metastatic effects of 4-[3,5-bis(trimethylsilyl)benzamido]benzoic acid (TAC-101) were investigated using our established lung cancer model. Orthotopic implantation of Lewis lung carcinoma (LLC) cells into the lung parenchyma produced a solitary tumor nodule in the lung followed by mediastinal lymph node metastasis. Daily oral administration of TAC-101 at doses ranging from 4 to 16 mg/kg resulted in a significant inhibition of lymphatic metastasis (inhibition rate=57 to 76%), while only the dose of 16 mg/kg significantly inhibited tumor growth at the implanted sites (inhibition rate=46%). Combined treatment with cis-diamminedichloroplatinum (CDDP) and TAC-101 (8 mg/kg, p.o., daily) enhanced the anti-tumor effect of CDDP (7 mg/kg, i.v., bolus) against both the growth of implanted tumor and lymphatic metastasis. In addition, this combined treatment significantly prolonged the survival time of LLC tumor-bearing mice as compared to treatment with each agent alone. The anti-activating protein-1 (AP-1) activity of TAC-101 caused inhibition of LLC cell invasion through the repression of expression of urokinase-type plasminogen activator and its receptor. The anti-invasive activity of TAC-101 may be involved in its in vivo anti-metastatic activity. These findings suggest that TAC-101 is a novel anti-cancer agent that may improve the therapeutic modalities for lung cancer patients with metastatic disease.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Antineoplastic Agents/pharmacology , Benzoates/pharmacology , Carcinoma, Lewis Lung/drug therapy , Lung Neoplasms/drug therapy , Lymphatic Metastasis/prevention & control , Trimethylsilyl Compounds/pharmacology , Animals , Carcinoma, Lewis Lung/metabolism , Carcinoma, Lewis Lung/secondary , Cisplatin/pharmacology , Drug Screening Assays, Antitumor , Female , Lung Neoplasms/metabolism , Lung Neoplasms/pathology , Mediastinum , Mice , Mice, Inbred C57BL , Neoplasm Invasiveness , Neoplasm Transplantation , Reverse Transcriptase Polymerase Chain Reaction , Transcription Factor AP-1/metabolism , Urokinase-Type Plasminogen Activator/metabolism
20.
Nihon Naika Gakkai Zasshi ; 88(12): 2355-60, 1999 Dec 10.
Article in Japanese | MEDLINE | ID: mdl-10629992
SELECTION OF CITATIONS
SEARCH DETAIL
...